Stemell is dedicated to the ongoing research and improvement of umbilical cord allograft regenerative products. Through our proprietary manufacturing process, we have developed premium, highly purified products which yield a much higher viability than competing products.

Our passion is driven by the simple fact that a better product yields better results.


Safety & Sterility

Stemell products are registered with the FDA, Tissue Bank, NIH and FWA. We operate out of a Certified Class 100 Clean Room and strictly follow GMP, GLP & GTP good manufacturing practices.



3rd party product testing and comparison has shown that Stemell yields 38% more viable product on average compared to other products at 3.2% viable product and less; some Stemell batches report even higher results.

3rd party testing results from DRIK LLC available upon request.


14 diseases tested

Infectious Disease

HIV I and II


Hepatitis B

Hepatitis C

Chagas Disease




West Nile Virus


Lyme Disease



Comprehensive testing is required for all donors before any umbilical cord blood for allografts is procured.  All Stemell products are tested for microbial and viral pathogens in addition to infectious diseases. 

Stemell goes above and the requirements by testing for 14 diseases instead of the standard 8. Official results for all testing are provided with every order.

free training &

marketing support

In addition to our premium product offerings, Stemell provides various marking tools for your practice  and ongoing support. As your partner in regenerative therapy, we offer a personable and customized approach.

Become a preferred Stemell distributor today.  

How to Order

Initial registration is required to place your first order. Visit our registration and ordering page.


Please use the form below if you have any questions regarding our products, how they can be utilized in patient care or how to become a distributor. For a faster response, feel free to call us at 949-481-1344.




For Medical Professional Viewing Only


Stemell, Inc. does not claim that therapy using StemL products cures or prevents any condition, disease or injury. All statements and opinions provided are for educational and informational purposes only, and we do not diagnose or provide medical or legal advice.

Individuals interested in any cellular or cell-free regenerative medicine therapy are urged to review all pertinent information and do their own research and due diligence before choosing to participate in any therapies. Please consult with your physician for further information and be sure to discuss any potential risks.

Please understand that Stemell, Inc. is a supplier only. Stemell, Inc. is not a sponsor, and Stemell, Inc. is not claiming to cure or treat any disorder or condition.

This site was intended for education purposes only and strictly for use by medical professionals. The FDA recently re-confirmed, there is only one registered stem cell product, and while there is enormous promise in stem cell therapies, and thousands of ongoing experimental applications trying to establish efficacy, these are not at the point where they would meet the scientific standard.

The FDA has stated:
Stem cells, like other medical products that are intended to treat, cure or prevent disease, generally require FDA approval before they can be marketed. FDA has not approved any stem cell-based products for use, other than cord blood-derived hematopoietic progenitor cells (blood forming stem cells) for certain indications.

This site is not intended for consumers.
If you are considering stem cell treatment in the U.S., ask your physician if the necessary FDA approval has been obtained or if you will be part of an FDA-regulated clinical study. This also applies if the stem cells are your own. Even if the cells are yours, there are safety risks, including risks introduced when the cells are manipulated after removal.

“There is a potential safety risk when you put cells in an area where they are not performing the same biological function as they were when in their original location in the body.” Cells in a different environment may multiply, form tumors, or may leave the site you put them in and migrate somewhere else. If you are considering having stem cell treatment in another country, learn all you can about regulations covering the products in that country. Exercise caution before undergoing treatment with a stem cell-based product in a country that—unlike the U.S.—may not require clinical studies designed to demonstrate that the product is safe and effective. FDA does not regulate stem cell treatments used solely in countries other than the United States and typically has little information about foreign establishments or their stem cell products.

Stem cell therapies have enormous promise, but the science in each use is still in the developmental stage. Professional judgment and expertise is needed in using stem cells for any therapeutic use, and we urge anyone embarking on the use of stem cell therapies to consult the national health data bases to evaluate current information from clinical trials and the FDA websites on human tissue should also be consulted to get its current evaluation of any therapy.